{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:47Z","timestamp":1790916827700,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"vor","delay-in-days":143,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101258","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:31:45Z","timestamp":1779676305000},"page":"101258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["EpCAM: A multifunctional protein at the crossroads of cancer biology, diagnosis, and immunotherapy"],"prefix":"10.1016","volume":"48","author":[{"given":"Mehrzad","family":"Ghari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0386-1717","authenticated-orcid":false,"given":"Fatemeh","family":"Ghaemimanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101258_bib0001","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1073\/pnas.76.3.1438","article-title":"Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies","volume":"76","author":"Herlyn","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ctarc.2026.101258_bib0002","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1083\/jcb.139.5.1337","article-title":"Epithelial cell adhesion molecule (Ep-CAM) modulates cell\u2013cell interactions mediated by classic cadherins","volume":"139","author":"Litvinov","year":"1997","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0003","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12929-024-01057-y","article-title":"Intracellular domain of epithelial cell adhesion molecule induces wnt receptor transcription to promote colorectal cancer progression","volume":"31","author":"Panda","year":"2024","journal-title":"J. Biomed. Sci"},{"key":"10.1016\/j.ctarc.2026.101258_bib0004","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/bjc.2013.80","article-title":"EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer","volume":"108","author":"Soysal","year":"2013","journal-title":"Br J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/jcp.2011.090274","article-title":"EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis","volume":"64","author":"Spizzo","year":"2011","journal-title":"J. Clin. Pathol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0006","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12957-021-02469-y","article-title":"Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer","volume":"20","author":"Kalantari","year":"2022","journal-title":"World J. Surg. Oncol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0007","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1309\/H8JEEAEB69J3KYND","article-title":"Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables","volume":"129","author":"Prince","year":"2008","journal-title":"Am. J. Clin. Pathol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47580-0","article-title":"EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma","volume":"13","author":"Kocheise","year":"2023","journal-title":"Sci. Rep"},{"key":"10.1016\/j.ctarc.2026.101258_bib0009","first-page":"314","article-title":"Molecular cloning and characterization of a human adenocarcinoma\/epithelial cell surface antigen complementary DNA","volume":"49","author":"Strnad","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctarc.2026.101258_bib0010","first-page":"1061","article-title":"CpG island methylation status in the EpCAM promoter region and gene expression","volume":"20","author":"Yu","year":"2008","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.ctarc.2026.101258_bib0011","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ijc.23476","article-title":"Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation","volume":"123","author":"van der Gun","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0012","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/bjc.2011.231","article-title":"Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer","volume":"105","author":"van der Gun","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0013","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.canlet.2006.03.002","article-title":"Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue","volume":"246","author":"Spizzo","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ctarc.2026.101258_bib0014","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1038\/ncomms5764","article-title":"Crystal structure and its bearing towards an understanding of key biological functions of EpCAM","volume":"5","author":"Pav\u0161i\u010d","year":"2014","journal-title":"Nat. Commun"},{"key":"10.1016\/j.ctarc.2026.101258_bib0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/biom10020255","article-title":"Revisiting the roles of pro-metastatic EpCAM in cancer","volume":"10","author":"Mohtar","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ctarc.2026.101258_bib0016","first-page":"025","article-title":"Biological roles and clinical applications of EpCAM in HCC","volume":"16","author":"Liu","year":"2025","journal-title":"Discov. Oncol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0017","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.2741\/2911","article-title":"EpCAM expression in normal, non-pathological tissues","volume":"13","author":"Schmelzer","year":"2008","journal-title":"Front. Biosci.-Landmark"},{"key":"10.1016\/j.ctarc.2026.101258_bib0018","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.bjc.6602924","article-title":"Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers","volume":"94","author":"Went","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0019","doi-asserted-by":"crossref","first-page":"421","DOI":"10.62347\/EGXS1506","article-title":"Association between EPCAM upregulation and clinicopathological parameters and outcomes of breast cancer","volume":"17","author":"Nafissi","year":"2024","journal-title":"Int. J. Clin. Exp. Pathol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0020","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1007\/s00432-023-04809-9","article-title":"EpCAM tumor specificity and proteoform patterns in urothelial cancer","volume":"149","author":"Dressler","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0021","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41419-017-0013-8","article-title":"Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN\/AKT\/mTOR pathway","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ctarc.2026.101258_bib0022","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/biom11070956","article-title":"Gillanders WE. Functional implications of the dynamic regulation of EpCAM during epithelial-to-mesenchymal transition","volume":"11","author":"Brown","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ctarc.2026.101258_bib0023","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/1471-2407-12-523","article-title":"Immunohistochemical analysis based ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma","volume":"12","author":"Kunavisarut","year":"2012","journal-title":"Bmc. Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0024","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/jcp.2011.090274","article-title":"EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis","volume":"64","author":"Spizzo","year":"2011","journal-title":"J. Clin. Pathol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/life15010126","article-title":"Post-translational modifications of proteins orchestrate all hallmarks of cancer","volume":"15","author":"Bruno","year":"2025","journal-title":"Life"},{"key":"10.1016\/j.ctarc.2026.101258_bib0026","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/biom10020255","article-title":"Revisiting the roles of pro-metastatic EpCAM in cancer","volume":"10","author":"Mohtar","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ctarc.2026.101258_bib0027","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.2741\/3075","article-title":"Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM","volume":"Volume","author":"Munz","year":"2008","journal-title":"Front. Biosci.-Landmark"},{"key":"10.1016\/j.ctarc.2026.101258_bib0028","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/biomedicines12051129","article-title":"Regulation of the function and expression of EpCAM","volume":"12","author":"Xiao","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ctarc.2026.101258_bib0029","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1002\/jcp.27256","article-title":"Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells","volume":"234","author":"Liu","year":"2019","journal-title":"J. Cell. Physiol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/030098589703400113","article-title":"Cell adhesion molecules-update","volume":"34","author":"Elangbam","year":"1997","journal-title":"Vet Pathol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0031","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1242\/bio.059403","article-title":"EPCAM and TROP2 share a role in claudin stabilization and development of intestinal and extraintestinal epithelia in mice","volume":"11","author":"Szabo","year":"2022","journal-title":"Biol Open"},{"key":"10.1016\/j.ctarc.2026.101258_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112533","article-title":"Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer","volume":"42","author":"Saini","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.ctarc.2026.101258_bib0033","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/jcp.24802","article-title":"Epithelial-to-mesenchymal transition induced by TGF-\u03b21 is mediated by AP1-dependent EpCAM expression in MCF-7 cells","volume":"230","author":"Gao","year":"2015","journal-title":"J. Cell Physiol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0034","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0014-4827(02)00045-9","article-title":"Expression of EpCAM shifts the state of cadherin-mediated adhesions from strong to weak","volume":"285","author":"Winter","year":"2003","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.ctarc.2026.101258_bib0035","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbamem.2013.04.018","article-title":"EpCAM: structure and function in health and disease","volume":"1828","author":"Schnell","year":"2013","journal-title":"Biochimica et Biophys. Acta (BBA)-Biomembrane"},{"key":"10.1016\/j.ctarc.2026.101258_bib0036","first-page":"E889","article-title":"Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal langerhans cell motility and migration in vivo","volume":"109","author":"Gaiser","year":"2012","journal-title":"Proceed. Nation. Acad. Sci"},{"key":"10.1016\/j.ctarc.2026.101258_bib0037","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ctrv.2011.04.002","article-title":"Epithelial cell adhesion molecule expression (CD326) in cancer: a short review","volume":"38","author":"Patriarca","year":"2012","journal-title":"Cancer Treat. Rev"},{"key":"10.1016\/j.ctarc.2026.101258_bib0038","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jons.2017.04.002","article-title":"EpCAM as a novel therapeutic target for hepatocellular carcinoma","volume":"3","author":"Vasanthakumar","year":"2017","journal-title":"J. Oncologic. Sci"},{"key":"10.1016\/j.ctarc.2026.101258_bib0039","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ncb1824","article-title":"Nuclear signalling by tumour-associated antigen EpCAM","volume":"11","author":"Maetzel","year":"2009","journal-title":"Nat. Cell Biol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2353\/ajpath.2007.070152","article-title":"Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule","volume":"171","author":"Trzpis","year":"2007","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008543","article-title":"Abnormal placental development and early embryonic lethality in EpCAM-null mice","volume":"4","author":"Nagao","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.ctarc.2026.101258_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049302","article-title":"mTrop1\/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin\/\u03b2-catenin","volume":"7","author":"Guerra","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ctarc.2026.101258_bib0043","doi-asserted-by":"crossref","first-page":"G278","DOI":"10.1152\/ajpgi.00286.2013","article-title":"Functional consequences of EpCam mutation in mice and men","volume":"306","author":"Mueller","year":"2014","journal-title":"Am. J. Physiol.-Gastrointestin.d Liver Physiol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000563","article-title":"The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development","volume":"5","author":"Slanchev","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ctarc.2026.101258_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-20131-8","article-title":"Spatiotemporal patterning of EpCAM is important for murine embryonic endo-and mesodermal differentiation","volume":"8","author":"Sarrach","year":"2018","journal-title":"Sci. Rep"},{"key":"10.1016\/j.ctarc.2026.101258_bib0046","doi-asserted-by":"crossref","unstructured":"Keller L., Werner S., Pantel K. Biology and clinical relevance of EpCAM. Cell stress. 2019;3:165.","DOI":"10.15698\/cst2019.06.188"},{"key":"10.1016\/j.ctarc.2026.101258_bib0047","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3390\/cells9081836","article-title":"Epithelial cell adhesion molecule: an anchor to isolate clinically relevant circulating tumor cells","volume":"9","author":"Eslami-S","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ctarc.2026.101258_bib0048","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/carcin\/bgq187","article-title":"EpCAM in carcinogenesis: the good, the bad or the ugly","volume":"31","author":"van der Gun","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ctarc.2026.101258_bib0049","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1158\/0008-5472.CAN-07-0908","article-title":"Activation of hepatic stem cell marker EpCAM by Wnt\u2013\u03b2-catenin signaling in hepatocellular carcinoma","volume":"67","author":"Yamashita","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctarc.2026.101258_bib0050","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbrc.2014.12.097","article-title":"EpCAM is up-regulated by EGF via ERK1\/2 signaling and suppresses human epithelial ovarian cancer cell migration","volume":"457","author":"Fan","year":"2015","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.ctarc.2026.101258_bib0051","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2018.06.040","article-title":"Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells","volume":"433","author":"Liang","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ctarc.2026.101258_bib0052","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40164-022-00352-4","article-title":"Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside","volume":"11","author":"Liu","year":"2022","journal-title":"Exp. Hematol. Oncol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0053","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1002\/jcp.29252","article-title":"Hypoxia modulates stem cell properties and induces EMT through N-glycosylation of EpCAM in breast cancer cells","volume":"235","author":"Zhang","year":"2020","journal-title":"J. Cell Physiol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0054","first-page":"27","article-title":"The clinicopathological significance of YAP\/TAZ expression in hepatocellular carcinoma with relation to hypoxia and stemness","author":"Park","year":"2021","journal-title":"Pathol. Oncol. Res"},{"key":"10.1016\/j.ctarc.2026.101258_bib0055","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1172\/JCI88428","article-title":"Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis","volume":"127","author":"Wu","year":"2017","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.ctarc.2026.101258_bib0056","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM199402033300508","article-title":"Care of patients with ascites","volume":"330","author":"Runyon","year":"1994","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.ctarc.2026.101258_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1371-1","article-title":"Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro","volume":"15","author":"Seeber","year":"2015","journal-title":"Bmc Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0058","doi-asserted-by":"crossref","first-page":"25017","DOI":"10.18632\/oncotarget.4496","article-title":"Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab","volume":"6","author":"Seeber","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctarc.2026.101258_bib0059","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra061808","article-title":"Cancer stem cells","volume":"355","author":"Jordan","year":"2006","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101258_bib0060","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3892\/ol.2014.1907","article-title":"Expression and clinical significance of colorectal cancer stem cell marker EpCAMhigh\/CD44+ in colorectal cancer","volume":"7","author":"Liu","year":"2014","journal-title":"Oncol. Lett"},{"key":"10.1016\/j.ctarc.2026.101258_bib0061","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1073\/pnas.1120733109","article-title":"Human ovarian cancer stem\/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance","volume":"109","author":"Meirelles","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ctarc.2026.101258_bib0062","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2008.12.004","article-title":"EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem\/progenitor cell features","volume":"136","author":"Yamashita","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctarc.2026.101258_bib0063","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/ijc.29921","article-title":"EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation","volume":"138","author":"Hiraga","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0064","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41392-024-01938-6","article-title":"Circulating tumor cells: from new biological insights to clinical practice","volume":"9","author":"Gu","year":"2024","journal-title":"Signal Transduct. Target. Therapy"},{"key":"10.1016\/j.ctarc.2026.101258_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237308","article-title":"Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients","volume":"15","author":"Drucker","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ctarc.2026.101258_bib0066","doi-asserted-by":"crossref","DOI":"10.1177\/1849454418782617","article-title":"Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin","volume":"7","author":"Po","year":"2018","journal-title":"J. Circ. Biomark"},{"key":"10.1016\/j.ctarc.2026.101258_bib0067","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1373\/clinchem.2015.249706","article-title":"Circulating tumor cells: a review of non\u2013EpCAM-based approaches for cell enrichment and isolation","volume":"62","author":"Gabriel","year":"2016","journal-title":"Clin. Chem"},{"key":"10.1016\/j.ctarc.2026.101258_bib0068","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-4939-7144-2_9","article-title":"Enrichment and detection of circulating tumor cells and other rare cell populations by microfluidic filtration","author":"Pugia","year":"2017","journal-title":"Isolat Molecul. Characteriz. Circulat. Tumor Cell."},{"key":"10.1016\/j.ctarc.2026.101258_bib0069","first-page":"479","article-title":"Circulating tumor cell isolation: the assets of filtration methods with polycarbonate track-etched filters","volume":"27","author":"Dolfus","year":"2015","journal-title":"Chin J. Cancer Res"},{"key":"10.1016\/j.ctarc.2026.101258_bib0070","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/bjc.2011.294","article-title":"A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas","volume":"105","author":"Farace","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0071","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.19.6.066007","article-title":"Fourier ptychographic microscopy for filtration-based circulating tumor cell enumeration and analysis","volume":"19","author":"Williams","year":"2014","journal-title":"J. Biomed. Opt"},{"key":"10.1016\/j.ctarc.2026.101258_bib0072","article-title":"Filter characteristics influencing circulating tumor cell enrichment from whole blood","volume":"8","author":"Coumans","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ctarc.2026.101258_bib0073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-226","article-title":"Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells","volume":"14","author":"Cummings","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0074","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nprot.2014.044","article-title":"Microfluidic, marker-free isolation of circulating tumor cells from blood samples","volume":"9","author":"Karabacak","year":"2014","journal-title":"Nat. Protoc"},{"key":"10.1016\/j.ctarc.2026.101258_bib0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1039\/C3LC50618E","article-title":"UV activation of polymeric high aspect ratio microstructures: ramifications in antibody surface loading for circulating tumor cell selection","volume":"14","author":"Jackson","year":"2014","journal-title":"Lab. A Chip."},{"key":"10.1016\/j.ctarc.2026.101258_bib0076","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141166","article-title":"A novel strategy for detection and enumeration of circulating rare cell populations in metastatic cancer patients using automated microfluidic filtration and multiplex immunoassay","volume":"10","author":"Magbanua","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ctarc.2026.101258_bib0077","article-title":"Filtration parameters influencing circulating tumor cell enrichment from whole blood","volume":"8","author":"Coumans","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ctarc.2026.101258_bib0078","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.3390\/cells9092128","article-title":"EpCAM as modulator of tissue plasticity","volume":"9","author":"Fagotto","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.ctarc.2026.101258_bib0079","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10555-024-10172-z","article-title":"Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance","volume":"43","author":"Bhat","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ctarc.2026.101258_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.843604","article-title":"EpCAM as a novel biomarker for survivals in prostate cancer patients","volume":"10","author":"Liao","year":"2022","journal-title":"Front Cell Dev. Biol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0081","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/antib11020041","article-title":"Development of a novel anti-EpCAM monoclonal antibody for various applications","volume":"11","author":"Li","year":"2022","journal-title":"Antibodies"},{"key":"10.1016\/j.ctarc.2026.101258_bib0082","doi-asserted-by":"crossref","first-page":"020","DOI":"10.1186\/s11671-020-03334-9","article-title":"Anti-epcam aptamer (Syl3c)-functionalized liposome for targeted delivery of doxorubicin: in vitro and In vivo antitumor studies in mice bearing C26 colon carcinoma","volume":"15","author":"Mashreghi","year":"2020","journal-title":"Nanoscale Res. Lett"},{"key":"10.1016\/j.ctarc.2026.101258_bib0083","series-title":"editor. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers","first-page":"273","article-title":"Monoclonal antibodies for cancer immunotherapy","author":"Zarnani","year":"2021"},{"key":"10.1016\/j.ctarc.2026.101258_bib0084","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ijc.2910380109","article-title":"The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies","volume":"38","author":"G\u00f6ttlinger","year":"1986","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0085","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7150\/jca.2.309","article-title":"Novel monoclonal antibodies for cancer treatment: the trifunctional antibody catumaxomab (removab)","volume":"2","author":"Seimetz","year":"2011","journal-title":"J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0086","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ctrv.2010.03.001","article-title":"Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM\u2005\u00d7\u2005anti-CD3) as a targeted cancer immunotherapy","volume":"36","author":"Seimetz","year":"2010","journal-title":"Cancer Treat. Rev"},{"key":"10.1016\/j.ctarc.2026.101258_bib0087","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40265-025-02187-9","article-title":"Catumaxomab: first approval","volume":"85","author":"Syed","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.ctarc.2026.101258_bib0088","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/ijc.25423","article-title":"The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II\/III trial","volume":"127","author":"Heiss","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0089","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00262-013-1497-4","article-title":"An EpCAM\/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression","volume":"63","author":"Zhang","year":"2014","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1016\/j.ctarc.2026.101258_bib0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/annonc\/mdp314","article-title":"An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer","volume":"21","author":"Schmidt","year":"2010","journal-title":"Ann. Oncol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0091","first-page":"2025","article-title":"Novel human single-domain antibodies exert potent anti-tumor activity by targeting EGF-like repeat epitope of EpCAM","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0092","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.adg9721","article-title":"EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors","volume":"9","author":"Li","year":"2023","journal-title":"Sci. Adv"},{"key":"10.1016\/j.ctarc.2026.101258_bib0093","doi-asserted-by":"crossref","first-page":"022","DOI":"10.1186\/s40164-022-00352-4","article-title":"Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside","volume":"11","author":"Liu","year":"2022","journal-title":"Exp. Hematol. Oncol"},{"key":"10.1016\/j.ctarc.2026.101258_bib0094","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1186\/s12885-020-07580-z","article-title":"Hepatocellular carcinoma: intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype","volume":"20","author":"Krause","year":"2020","journal-title":"Bmc Cancer"},{"key":"10.1016\/j.ctarc.2026.101258_bib0095","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.7150\/thno.52614","article-title":"The current landscape of antibody-based therapies in solid malignancies","volume":"11","author":"Shah","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ctarc.2026.101258_bib0096","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1302354","article-title":"Targeting colorectal cancer cells using AND-gated adaptor RevCAR T-cells","volume":"14","author":"Soto","year":"2023","journal-title":"Front Immunol"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:58:56Z","timestamp":1790913536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226001693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":96,"alternative-id":["S2468294226001693"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101258","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EpCAM: A multifunctional protein at the crossroads of cancer biology, diagnosis, and immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101258"}}